US Stock MarketDetailed Quotes

FEMY Femasys

Watchlist

1.1150
-0.0050-0.45%

Trading Sep 13 11:09 ET

24.79MMarket Cap-1327P/E (TTM)

Femasys Stock Forum

Trytosaveabit

Sep 11 07:36

Update

$Femasys (FEMY.US)$ Reuters
·3 mins ago
Femasys Secures Strategic Distribution Partnerships for Commercialization of Femaseed® for Over $1.3M in Spanish Market

Jaguar8

Sep 11 07:32

NEWS

$Femasys (FEMY.US)$
Femasys Secures Strategic Distribution Partnerships for Commercialization of FemaSeed® for over $1.3M in Spanish Market
Share on Reddit
Share on Facebook
09/11/2024 - 05:30 AM
Company taps Comercial Medico Quirurigca, SA and Durgalab as first EU distributors for its CE-marked women’s reproductive healthcare products
ATLANTA, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of wome...

IAM

Sep 9 14:40

$Femasys (FEMY.US)$ with good news and went red. ? 🥴

Jaguar8

Sep 9 07:34

NEWS

$Femasys (FEMY.US)$
Femasys Inc. Receives U.S. FDA Clearance to Market FemChec®, an Innovative Diagnostic Solution for Fallopian Tube Check
ATLANTA, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (NASDAQ:FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of in-office, accessible, and innovative therapeutic and diagnostic products, today announced it has received 510(k) clearance from the United States Food and Drug Ad...

Trytosaveabit

Aug 29 07:35

News

$Femasys (FEMY.US)$ Femasys Announces Ce Mark and Canadian Approval for Femvue® Mini, a Fallopian Tube Assessment Solution

Kaylin Dad2010

Jun 20 14:15

$Femasys (FEMY.US)$ 8k report: On June 20, 2024, Femasys Inc., a biomedical company specializing in women's health, announced the receipt of CE Mark approval for four of its products, enabling the start of commercialization efforts in Europe. The approved products, which include FemaSeed, FemVue, FemCerv, and FemCath, comply with the European Union Medical Device Regulation (EU MDR). This regulatory milestone follows the company's recent completion of its commercial team in the United States and ...